Oscar Segurado

Chief Medical Officer - ASC Therapeutics

Executive veteran of the biopharmaceutical industry with extensive global leadership experience in translational science, clinical development and global medical affairs.


C-suite executive and industry leader providing in-depth expertise for pre-clinical and clinical study strategy, planning, execution and monitoring, regulatory interactions, investor relations, fundraising, M&A and IPO process and deliverables. 


Chief Medical Officer for ASC Therapeutics, former CMO for Symvivo, Myriad Genetics and CellMax Life, Vice President for Becton Dickinson and Global Medical Head for Abbott/AbbVie (Humira).


Author and co-author of over 100 peer-reviewed publications, including Nature, Lancet and Journal of Experimental Medicine, books and medical articles and member of several scientific and medical societies.


Holding a tenured Professorship of Immunology at the University of Leon, Spain. Received PhD from the University of Wuerzburg, Germany and MD from the University of Salamanca, Spain

Oscar Segurado


  • Thursday - September 22, 2022 - 14:45

    Panel Discussion - A collaborative clinical ecosystem: How to effectively manage partnerships with all Stakeholders including Patients, Sites, CROs, Sponsors and Regulators.

  • Thursday - September 22, 2022 - 17:25

    Decentralized Clinical Trials and Patient Centricity: Spotlight on Rare Diseases

    • Uses & challenges for Blockchain in Clinical Trials
    • Storing all types of data safely and securely
    • Better Clinical Trials Quality


Stay Informed

Subscribe today to receive news on latest updates,
offers and upcoming conferences via email

For general conference and registration enquires please contact the below email id or fill out the form

Enquire now